Browsing: advanced

A multi-institutional collaborative study led by researchers at the University of Chicago and the Fred Hutchinson Cancer Center has identified…

Patients with an advanced form of lung cancer lived 56 percent longer without their disease progressing when radiotherapy was added…

A new alpha-emitting radiopharmaceutical therapy (RPT) for advanced prostate cancer was well tolerated, with no dose-limiting toxicities observed, and showed…

An immunotherapy-based regimen combining durvalumab and the PARP inhibitor, olaparib, demonstrated encouraging long-term survival outcomes for patients with advanced or…

Results from a clinical trial have revealed nearly one third (29.2 percent) of patients with advanced melanoma saw their tumors…